1. Home
  2. GOVX vs AMS Comparison

GOVX vs AMS Comparison

Compare GOVX & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOVX
  • AMS
  • Stock Information
  • Founded
  • GOVX 2001
  • AMS 1980
  • Country
  • GOVX United States
  • AMS United States
  • Employees
  • GOVX N/A
  • AMS N/A
  • Industry
  • GOVX Biotechnology: Pharmaceutical Preparations
  • AMS Medical Specialities
  • Sector
  • GOVX Health Care
  • AMS Health Care
  • Exchange
  • GOVX Nasdaq
  • AMS Nasdaq
  • Market Cap
  • GOVX 17.1M
  • AMS 19.5M
  • IPO Year
  • GOVX N/A
  • AMS N/A
  • Fundamental
  • Price
  • GOVX $2.46
  • AMS $3.09
  • Analyst Decision
  • GOVX Strong Buy
  • AMS
  • Analyst Count
  • GOVX 5
  • AMS 0
  • Target Price
  • GOVX $14.20
  • AMS N/A
  • AVG Volume (30 Days)
  • GOVX 3.6M
  • AMS 19.9K
  • Earning Date
  • GOVX 11-12-2024
  • AMS 11-13-2024
  • Dividend Yield
  • GOVX N/A
  • AMS N/A
  • EPS Growth
  • GOVX N/A
  • AMS 566.31
  • EPS
  • GOVX N/A
  • AMS 0.66
  • Revenue
  • GOVX $3,090,161.00
  • AMS $23,104,000.00
  • Revenue This Year
  • GOVX N/A
  • AMS $29.39
  • Revenue Next Year
  • GOVX $565.58
  • AMS $16.22
  • P/E Ratio
  • GOVX N/A
  • AMS $4.30
  • Revenue Growth
  • GOVX N/A
  • AMS 13.49
  • 52 Week Low
  • GOVX $1.09
  • AMS $2.32
  • 52 Week High
  • GOVX $11.18
  • AMS $4.60
  • Technical
  • Relative Strength Index (RSI)
  • GOVX 52.48
  • AMS 47.64
  • Support Level
  • GOVX $2.31
  • AMS $2.85
  • Resistance Level
  • GOVX $3.88
  • AMS $3.24
  • Average True Range (ATR)
  • GOVX 0.32
  • AMS 0.14
  • MACD
  • GOVX 0.11
  • AMS -0.02
  • Stochastic Oscillator
  • GOVX 33.33
  • AMS 58.54

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

Share on Social Networks: